Clinical Trials
12 trialsNCT06992427 2026-05-11
HOPE
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT03574792 2026-04-16
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Phase 2 Completed
NCT04176419 2024-11-12
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
Phase 3 Terminated
NCT05156060 2024-10-21
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase 1/2 Recruiting
NCT03747562 2024-09-19
stREnGTH
University Hospital, Ghent
Phase 3 Withdrawn
NCT03423264 2024-07-31
PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing
University of Chicago
Phase 2 Withdrawn
NCT04246697 2023-08-18
Multimodal Pain Study in Free Flap Patients
University of Kansas Medical Center
Phase 4 Completed
NCT02531906 2022-07-25
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
Roswell Park Cancer Institute
Phase 1 Completed
NCT03269344 2022-01-26
Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer
Henry Ford Health System
Phase 3 Completed
NCT03682367 2021-07-09
Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery
University of California, Davis
Phase 3 Terminated
NCT02480114 2021-02-18
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Vanderbilt-Ingram Cancer Center
Phase 3 Completed
NCT02926573 2018-08-08
GABA
Washington University School of Medicine
Phase 4 Completed